Aevi Genomic Medicine (GNMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Operating Expenses | 2,443 | 4,577 | 3,669 | 3,081 | 3,949 |
| Operating Income | -2,443 | -4,577 | -3,669 | -3,081 | -3,949 |
| Other Income | 346 | 901 | 1,259 | 55 | -2,955 |
| Pre-tax Income | -2,097 | -3,676 | -2,410 | -3,026 | -6,904 |
| Income Tax | 2 | 3 | 10 | 1 | 8 |
| Net Income Continuous | -2,099 | -3,679 | -2,420 | -3,027 | -6,912 |
| Net Income | $-2,099 | $-3,679 | $-2,420 | $-3,027 | $-6,912 |
| EPS Basic Total Ops | -0.11 | -0.24 | -0.15 | -0.25 | -0.69 |
| EPS Basic Continuous Ops | -0.11 | -0.24 | -0.15 | -0.25 | -0.69 |
| EPS Diluted Total Ops | -0.11 | -0.29 | -0.15 | -0.25 | -0.69 |
| EPS Diluted Continuous Ops | -0.11 | -0.24 | -0.15 | -0.25 | -0.69 |
| EBITDA(a) | $-2,398 | $-4,538 | $-3,632 | $-3,045 | $-3,912 |